Tag Archives: Cancer

Basket Trials: Accelerating Precision Medicine

By | July 11, 2017

On May 23rd 2017, the cancer research community applauded a landmark accomplishment when for the first time the U.S. Food and Drug Administration (FDA) approved Merck’s pembrolizumabfor use in tumors located in any tissue. While cancers are traditionally organized and treated based on their tissue of origin, tumor sequencing has demonstrated that there are important… Read More »

My picks in Science Policy April 9th-15th

By | April 16, 2017

1. The problems with cancer research cell lines As a cancer biologists, there are several breast cancer cell lines I use every day. Some of these are derived from human tumors, some from mouse tumors that closely mimic what we see in human patients. However, we’ve known for a long time that cell lines don’t… Read More »